SIA
EXAS

Sit Investment Associates’s Exact Sciences EXAS Stock Holding History

Sit Investment Associates’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-53,915
Closed -$5.48M – 514
2025
Q4 		$5.48M Sell
53,915
-3,825
-7% -$307K 0.11% 193
2025
Q3 		$3.16M Sell
57,740
-240
-0.4% -$12K 0.06% 261
2025
Q2 		$3.08M Sell
57,980
-790
-1% -$40.1K 0.07% 260
2025
Q1 		$2.54M Sell
58,770
-7,755
-12% -$393K 0.06% 286
2024
Q4 		$3.74M Sell
66,525
-250
-0.4% -$15.6K 0.08% 247
2024
Q3 		$4.55M Buy
66,775
+35
+0.1% +$1.98K 0.1% 214
2024
Q2 		$2.82M Buy
66,740
+488
+0.7% +$26.9K 0.06% 255
2024
Q1 		$4.58M Buy
66,252
+22,227
+50% +$1.41M 0.11% 210
2023
Q4 		$3.26M Hold
44,025
– – 0.08% 253
2023
Q3 		$3M Hold
44,025
– – 0.08% 239
2023
Q2 		$4.13M Sell
44,025
-725
-2% -$56.6K 0.11% 212
2023
Q1 		$3.03M Sell
44,750
-9,175
-17% -$590K 0.08% 252
2022
Q4 		$2.67M Sell
53,925
-175
-0.3% -$7.15K 0.07% 259
2022
Q3 		$1.76M Hold
54,100
– – 0.05% 292
2022
Q2 		$2.13M Sell
54,100
-160
-0.3% -$8.56K 0.06% 274
2022
Q1 		$3.79M Sell
54,260
-2,015
-4% -$147K 0.1% 231
2021
Q4 		$4.38M Buy
56,275
+7,600
+16% +$671K 0.1% 231
2021
Q3 		$4.65M Hold
48,675
– – 0.12% 211
2021
Q2 		$6.05M Buy
48,675
+175
+0.4% +$20.9K 0.15% 190
2021
Q1 		$6.39M Buy
48,500
+600
+1% +$82.1K 0.17% 177
2020
Q4 		$6.35M Hold
47,900
– – 0.17% 181
2020
Q3 		$4.88M Hold
47,900
– – 0.14% 199
2020
Q2 		$4.16M Buy
47,900
+3,950
+9% +$316K 0.13% 198
2020
Q1 		$2.55M Hold
43,950
– – 0.1% 234
2019
Q4 		$4.06M Buy
43,950
+8,700
+25% +$765K 0.12% 210
2019
Q3 		$3.19M Buy
35,250
+4,000
+13% +$456K 0.1% 222
2019
Q2 		$3.69M Hold
31,250
– – 0.11% 209
2019
Q1 		$2.71M Sell
31,250
-3,600
-10% -$306K 0.09% 233
2018
Q4 		$2.2M Hold
34,850
– – 0.07% 251
2018
Q3 		$2.75M Buy
34,850
+1,550
+5% +$101K 0.07% 229
2018
Q2 		$1.99M Buy
33,300
+6,500
+24% +$350K 0.05% 282
2018
Q1 		$1.08M Buy
26,800
+3,200
+14% +$156K 0.03% 345
2017
Q4 		$1.24M Sell
23,600
-6,300
-21% -$336K 0.03% 347
2017
Q3 		$1.41M Buy
29,900
+18,750
+168% +$755K 0.04% 325
2017
Q2 		$394K Buy
+11,150
New +$344K 0.01% 434

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Sit Investment Associates's EXAS Position: Q1 2026 in Review

Sit Investment Associates sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 53,915 shares — an estimated $5.48M sold.

Sit Investment Associates first reported a position in EXAS in Q2 2017 and held it in 35 quarters. The position peaked at $6.39M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Sit Investment Associates reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Sit Investment Associates sold 53,915 Exact Sciences shares in Q1 2026, an estimated $5.48M.
  • Sit Investment Associates first reported a position in Exact Sciences in Q2 2017 and held it in 35 quarters.
  • Sit Investment Associates's Exact Sciences position peaked at $6.39M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Sit Investment Associates's 13F filing for Q1 2026, filed 13 May 2026.